Methamphetamine and HIV-1 gp120 effects on lipopolysaccharide stimulated matrix metalloproteinase-9 production by human monocyte-derived macrophages

Immunological Investigations

Volumn 40, Issue 5, 2011, Pages 481-497

  Reynolds, Jessica L ^a   Mahajan, Supriya D ^a   Aalinkeel, Ravikumar ^a   Nair, Bindukumar ^a   Sykes, Donald E ^a   Schwartz, Stanley A ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Gp120; Human immunodeficiency virus; Lipopolysaccharide; Matrix metalloproteinase; Methamphetamine; Monocyte derived mature macrophages

Indexed keywords

CENTRAL STIMULANT AGENT; GELATINASE B; GLYCOPROTEIN GP 120; IMMUNOLOGICAL ADJUVANT; LIPOPOLYSACCHARIDE; METHAMPHETAMINE; MITOGEN ACTIVATED PROTEIN KINASE P38;

ARTICLE; CELL CULTURE; CELL SURVIVAL; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MACROPHAGE; METABOLISM;

ADJUVANTS, IMMUNOLOGIC; CELL SURVIVAL; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM STIMULANTS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HIV ENVELOPE PROTEIN GP120; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES; MATRIX METALLOPROTEINASE 9; METHAMPHETAMINE; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 80053296425     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2011.559499     Document Type: Article

References (62)

1. Ancuta, P., Kamat, A., Kunstman, K. J., Kim, E. Y., Autissier, P., Wurcel, A., Zaman, T., Stone, D., Mefford, M., Morgello, S., Singer, E. J., Wolinsky, S. M., Gabuzda, D. (2008). Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS ONE 3(6):e2516. doi:10.1371/journal.pone.0002516.
2. Annunziata, P. (2003). Blood-brain barrier changes during invasion of the central nervous system by HIV-1. Old and new insights into the mechanism. J. Neurol. 250:901-906. (Pubitemid 37041018)
3. Baroncelli, S., Galluzzo, C. M., Pirillo, M. F., Mancini, M. G., Weimer, L. E., Andreotti, M., Amici, R., Vella, S., Giuliano, M., Palmisano, L. (2009). Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with <50copies/ml HIV-1 RNA. J. Clin. Virol. 46(4):367-370.
4. Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., Blazar, B. R., Rodriguez, B., Teixeira-Johnson, L, Landay, A.., Martin, J. N., Hecht, F. M., Picker, L. J., Lederman, M. M., Deeks, S. G., Douek, D. C. (2006). Microbial translocation is a cause of systemic immune activation in chonic HIV infection. Nat. Med. 12(12):1365-1371. (Pubitemid 44924494)
5. Brenchley, J. M., Douek, D. C. (2008). HIV infection and the gastrointestinal immune system. Mucosal Immunol. 1(1):23-30.
6. Buckner, C., Luers, A., Calderon, T., Eugenin, E., Berman, J. (2006). Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on NeuroAIDS. J. NeuroImmune Pharmacol. 1:160-181. (Pubitemid 44257491)
7. Cheung, R., Ravyn, V., Wang, L., Ptasznik, A., Collman, R. G. (2008). Signaling mechanism of HIV-1 gp120 and virion-induced IL-1beta release in primary human macrophages. J. Immunol. 180:6675-6684.
8. Ciccone, E. J., Read, S. W., Mannon, P. J., Yao, M. D., Hodge, J. N., Dewar, R., Chairez, C. L., Proschan, M. A., Kovacs, J. A., Sereti, I. (2010). Cycling of gut mucosal CD4+ T cells decreases after prolonged anti-retroviral therapy and is associated with plasma LPS levels. Mucosal Immunol. 3(2):172-181.
9. Conant, K., McArthur, J. C., Griffin, D. E., Sjulson, L., Wahl, L. M., Irani, D. N. (1999). Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann. Neurol. 46(3):391-398. (Pubitemid 29416277)
10. Conant, K., St Hillaire, C., Anderson, C., Galey, D., Wang, J., Nath, A. (2004). Human immunodeficiency virus type 1 Tat and methamphetamine affect the release and activation of matrix-degrading proteinases. J. Neurovirol. 10(1):21-28. (Pubitemid 38325106)
11. Dallasta, L. M., Pisarov, L. A., Esplen, J. E., Werley, J. V., Moses, A. V., Nelson, J. A., Achim, C. L. (1999). Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 155(6):1915-1927.
12. Davis, L. E., Hjelle, B. L., Miller, V. E., Palmer, D. L., Llewellyn, A. L., Merlin, T. L., Young, S. A, Mills, R. G., Wachsman, W., Wiley, C. A. (1992). Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 42:1736-1739.
13. Dhawan, S., Toro, L. A., Jones, B. E., Meltzer, M. S. (1992). Interaction between HIV-infected monocytes and the extracellular matrix: HIV-infected monocytes secrete neutral metalloproteases that degrade basement membrane protein matrices. J. Leukoc. Biol. 52:244-248.
14. Dzwonek, J., Rylski, M., Kaczmarek, L. (2004). Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain. FEBS Lett. 567(1):129-135. (Pubitemid 38686435)
15. Eugenin, E. A., Osiecki, K., Lopez, L., Goldstein, H., Calderon, T. M., Berman, J. W. (2006). CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: A potential mechanism of HIV-CNS invasion and neuroAIDS. J. Neurosci. 26:1098-1106. (Pubitemid 43237041)
16. Ferris, M. J., Mactutus, C. F., Booze, R. M. (2008). Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS. Neurosci. Biobehav. Rev. 32:883-909.
17. Friedman, H., Newton, C., Klein, T. W. (2003). Microbial infections, immunomodulation, and drugs of abuse. Clin. Microbiol. Rev. 16:209-219. (Pubitemid 36519808)
18. Gaskill, P. J., Calderon, T. M., Luers, A. J., Eugenin, E. A., Javitch, J. A., Berman, J. W. (2009). Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse. Am. J. Pathol. 175(3):1148-1159.
19. Gendelman, H. E., Persidsky, Y., Ghorpade, A., Limoges, J., Stins, M., Fiala, M., Morrisett, R. (1997). The neuropathogenesis of the AIDS dementia complex. AIDS 11 Suppl A: S35-45.
20. Ghorpade, A., Persidskaia, R., Suryadevara, R., Che, M., Liu, X. J., Persidsky, Y., Gendelman, H. E. (2001). Mononuclear phagocyte differentiation, activation, and viral infection regulate matrix metalloproteinase expression: implications for human immunodeficiency virus type 1-associated dementia. J. Virol. 75(14):6572-6583. (Pubitemid 32578177)
21. Gras, G., Kaul, M. (2010). Molecular mechanisms of neuroinvasion by monocytesmacrophages in HIV-1 infection. Retrovirology 7:30.
22. Hamamoto, D. T., Rhodus, N. L. (2009). Methamphetamine abuse and dentistry. Oral Dis. 15(1):27-37.
23. Herbein, G., Varin, A. (2010). The macrophage in HIV-1 infection: from activation to deactivation? Retrovirology 7:33.
24. Jiang, W., Lederman, M. M., Hunt, P., Sieg, S. F., Haley, K., Rodriguez, B., Landay, A., Martin, J., Sinclair, E., Asher, A. I., Deeks. S. G., Douek, D. C., Brenchley, J. M. (2009). Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restorationin persons with antiretroviral-treated HIV infection. J. Infect. Dis. 199(8):1177-1185.
25. Ju, S. M., Song, H. Y., Lee, J. A., Lee, S. J., Choi, S. Y., Park, J. (2009). Extracellular HIV-1 Tat up-regulates expression of matrix metalloproteinase-9 via a MAPK-NF-kappaB dependent pathway in human astrocytes. Exp. Mol. Med. 41(2):86-93.
26. Kaczmarek, L., Lapinska-Dzwonek, J., Szymczak, S. (2002). Matrix metalloproteinases in the adult brain physiology: a link between c-Fos, AP-1 and remodeling of neuronal connections? EMBO J. 21(24):6643-6648. (Pubitemid 36014536)
27. Kaul, M., Lipton, S. A. (1999). Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc. Natl. Acad. Sci. USA 96:8212-8216. (Pubitemid 29328434)
28. Kaul, M., Ma, Q., Medders, K. E., Desai, M. K., Lipton, S. A. (2007). HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection. Cell Death Differ. 14:296-305. (Pubitemid 46092232)
29. Kumar, A., Dhawan, S., Mukhopadhyay, A., Aggarwal, B. B. (1999). Human immunodeficiency virus-1-tat induces matrix metalloproteinase-9 in monocytes though protein tyrosine phosphatase-mediated activation of nuclear transcription factor NF-kappaB. FEBS Lett. 462(1-2):140-144.
30. Lai, W. C., Zhou, M., Shankavaram, U., Peng, G., Wahl, L. M. (2003). Differential regulation of lipopolysaccharide-induced monocyte matrix metalloproteinase (MMP)-1 and MMP-9 by p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J. Immunol. 170(12):6244-6249. (Pubitemid 36682609)
31. Leber, T. M., Balkwill, F. R. (1998). Regulation of monocyte MMP-9 production by TNF-alpha and a tumour-derived soluble factor (MMPSF). Br. J. Cancer 78(6):724-732. (Pubitemid 28418303)
32. Leber, T. M, Balkwill, F. R. (1997). Zymography: A single-step staining method for quantitation of proteolytic activity on substrate gels. Anal. Biochem. 249(1):24-28. (Pubitemid 27251938)
33. Lee, W. J., Shin, C. Y., Yoo, B. K., Ryu, J. R., Choi, E. Y., Cheong, J. H., Ryu, J. H., Ko, K. H. (2003). Induction of matrix metalloproteinase-9(MMP-9) in lipopolysaccharide-stimulated primary astrocytes is mediated by extracellular signal-regulated protein kinase 1/2 (Erk1/2). Glia 41 (1):15-24. (Pubitemid 36164281)
34. Liuzzi, G. M., Mastroianni, C. M., Santacroce, M. P., Fanelli, M., D'Agostino, C., Vullo, V., Riccio, P. (2000). Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases. J. Neurovirol. 6(2):156-163. (Pubitemid 30303574)
35. Louboutin, J. P., Agrawal, L., Reyes, B. A., Van Bockstaele, E. J., Strayer, D. S. (2010). HIV-1 gp120-induced injury to the blood-brain barrier: role of metalloproteinases 2 and 9 and relationship to oxidative stress. J. Neuropathol. Exp. Neurol. 69(8):801-816.
36. Lu, Y., Wahl, L. M. (2005). Production of matrix metalloproteinase-9 by activated human monocytes involves a phosphatidylinositol-3 kinase/Akt/IKKalpha/ NF-kappaB pathway. J. Leukoc. Biol. 78(1):259-265. (Pubitemid 40979965)
37. Mahajan, S. D., Aalinkeel, R., Reynolds, J. L., Nair, B. B., Fernandez, S. F., Schwartz, S. A, Nair, M. P. (2005). Morphine exacerbates HIV-1 viral protein gp120 induced modulation of chemokine gene expression in U373 astrocytoma cells. Curr. HIV Res. 3(3):277-288. (Pubitemid 41052427)
38. Mannello, F., Gazzanelli, G. (2001). Tissue inhibitors of metalloproteinases and programmed cell death: conundrums, controversies and potential implications. Apoptosis 6(6):479-482. (Pubitemid 33078759)
39. Medders, K. E., Sejbuk, N. E., Maung, R., Desai, M. K., Kaul, M. (2010). Activation of p38 MAPK is required in monocytic and neuronal cells for HIV glycoprotein 120-induced neurotoxicity. J. Immunol. 185(8):4883-4895.
40. Missé, D., Esteve, P. O., Renneboog, B., Vidal, M., Cerutti, M., StPierre, Y., Yssel, H., Parmentier, M., Veas, F. (2001). HIV-1 glycoprotein 120 induces the MMP-9 cytopathogenic factor production that is abolished by inhibition of the p38 mitogen-activated protein kinase signaling pathway. Blood 98(3):541-547.
41. Mizoguchi, H., Yamada, K., Niwa, M., Mouri, A., Mizuno, T., Noda, Y., Nitta, A., Itohara, S., Banno, Y., Nabeshima, T. (2007a). Reduction of methamphetamine-induced sensitization and reward in matrix metalloproteinase-2 and -9-deficient mice. J. Neurochem. 100(6):1579-1588. (Pubitemid 46376198)
42. Mizoguchi, H., Yamada, K., Mouri, A., Niwa, M., Mizuno, T., Noda, Y., Nitta, A., Itohara, S., Banno, Y., Nabeshima, T. (2007b). Role of matrix metalloproteinase and tissue inhibitor of MMP in methamphetamine-induced behavioral sensitization and reward: implications for dopamine receptor down-regulation and dopamine release. J. Neurochem. 102(5):1548-1560. (Pubitemid 47256194)
43. Mun-Bryce, S., Rosenberg, G. A. (1998). Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. Am. J. Physiol. 274 (5 Pt 2): R1203-1211.
44. Nath, A., Maragos, W. F., Avison, M. J., Schmitt, F. A., Berger, J. R. (2001). Acceleration of HIV dementia with methamphetamine and cocaine. J. Neurovirol. 7(1):66-71. (Pubitemid 32904361)
45. Perfettini, J. L., Castedo, M., Nardacci, R., Ciccosanti, F., Boya, P., Roumier, T., Larochette, N., Piacentini, M., Kroemer, G. (2005). Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope. J. Exp. Med. 201(2):279-289. (Pubitemid 40189437)
46. Power, C., Kong, P. A., Crawford, T. O., Wesselingh, S., Glass, J. D., McArthur, J. C., Trapp, B. D. (1993). Cerebral white matter changes in acquired immunodeficiency syndrome dementia: Alterations of the blood-brain barrier. Ann. Neurol. 34(3):339-350. (Pubitemid 23259602)
47. Rhee, J. W., Lee, K. W., Kim, D., Lee, Y., Jeon, O. H., Kwon, H. J., Kim, D. S. (2007). NF-kappaB-dependent regulation of matrix metalloproteinase-9 gene expression by lipopolysaccharide in a macrophage cell line RAW 264. 7. J. Biochem. Mol. Biol. 40(1):88-94. (Pubitemid 46182740)
48. Rhodes, R. H. (1991). Evidence of serum-protein leakage across the blood-brain barrier in the acquired immunodeficiency syndrome. J. Neuropathol. Exp. Neurol. 50(2):171-183.
49. Serra, R., Al-Saidi, A. G., Angelov, N., Nares, S. (2010). Suppression of LPS-induced matrix-metalloproteinase responses in macrophages exposed to phenytoin and its metabolite, 5-(p-hydroxyphenyl-), 5-phenylhydantoin. J. Inflamm. (Lond). 7:48.
50. Shively, L., Chang, L., Le Bon, J. M., Liu, Q., Riggs, A. D., Singer-Sam, J. (2003). Realtime PCR assay for quantitative mismatch detection. BioTechniques 34:498-502.
51. Speidl, W. S., Toller, W. G., Kaun, C., Weiss, T. W., Pfaffenberger, S., Kastl, S. P., Furnkranz, A., Maurer, G., Huber, K., Metzler, H., Wojta, J. (2004). Catecholamines potentiate LPS-induced expression of MMP-1 and MMP-9 in human monocytes and in the human monocytic cell line U937: possible implications for peri-operative plaque instability. FASEB J. 18(3):603-605.
52. Sporer, B., Paul, R., Koedel, U., Grimm, R., Wick, M., Goebel, F. D., Pfister, H. W. (1998). Presence of matrix metalloproteinase-9 activity in the cerebrospinal fluid of human immunodeficiency virus infected patients. J. Infect. Dis. 178:854-857. (Pubitemid 28397237)
53. Tallóczy, Z., Martinez, J., Joset, D., Ray, Y., Gácser, A., Toussi, S., Mizushima, N., Nosanchuk, J. D., Goldstein, H., Loike, J., Sulzer, D., Santambrogio, L. (2008). Methamphetamine inhibits antigen processing, presentation, and phagocytosis. PLoS Pathog. 4(2):e28.
54. Tipton, D. A., Legan, Z. T., Dabbous, M. K. (2010). Methamphetamine cytotoxicity and effect on LPS-stimulated IL-1beta production by human monocytes. Toxicol. In Vitro. 24(3):921-927.
55. Van Den Steen, P. E., Dubois, B., Nelissen, I., Rudd, P. M., Dwek, R. A., Opdenakker, G. (2002). Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9(MMP-9). Crit. Rev. Biochem. Mol. Biol. 37 (6):375-536. (Pubitemid 36071972)
56. Visse, R., Nagase, H. (2003). Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92(8):827-839. (Pubitemid 36542523)
57. Vos, C. M., Gartner, S., Ransohoff, R. M., McArthur, J. C., Wahl, L., Sjulson, L., Hunter, E., Conant, K. (2000). Matrix metalloprotease-9 release from monocytes increases as a function of differentiation: implications for neuroinflammation and neurodegeneration. J. Neuroimmunol. 109(2):221-227.
58. Webster, N. L., Crowe, S. M. (2006). Matrix metalloproteinases, their production by monocytes and macrophages and their potential role in HIV-related diseases. J. Leukoc. Biol. 80(5):1052-1066. (Pubitemid 44646311)
59. Westhorpe, C. L., Zhou, J., Webster, N. L., Kalionis, B., Lewin, S. R., Jaworowski, A., Muller, W. A., Crowe, S. M. (2009). Effects of HIV-1 infection in vitro on transendothelial migration by monocytes and monocyte-derived macrophages. J. Leukoc. Biol. 85(6):1027-1035.
60. Williams, K. C., Hickey, W. F. (2002). Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu. Rev. Neurosci. 25:537-562. (Pubitemid 34748028)
61. Wu, D. T., Woodman, S. E., Weiss, J. M., McManus, C. M., D'Aversa, T. G., Hesselgesser, J. (2000). Major EO, Nath A, Berman JW. Mechanisms of leukocyte trafficking into the CNS. J. Neurovirol. 6 (Suppl 1): S82-S85. (Pubitemid 30342781)
62. Zhen, X., Uryu, K., Wang, H. Y., Friedman, E. (1998). D1 dopamine receptor agonists mediate activation of p38 mitogen-activated protein kinase and c-Jun. amino-terminal kinase by a protein kinase A-dependent mechanism in SK-N-MC human neuroblastoma cells. Mol. Pharmacol. 54(3):453-458. (Pubitemid 28442937)